AI assistant
Marksans Pharma Ltd. — Call Transcript 2026
May 19, 2026
62142_rns_2026-05-19_22ba2133-a38e-4fcc-8216-27aecd8e2f2c.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [47 x 46] intentionally omitted <==
==> picture [86 x 18] intentionally omitted <==
==> picture [110 x 18] intentionally omitted <==
May 19, 2026
BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai – 400001. Bandra (East), Mumbai – 400051. Scrip Code: 524404 Symbol: MARKSANS
Subject: Intimation of schedule for Q4FY26 Earnings Conference Call
Dear Sir/Madam,
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled a conference call for analysts and investors on Wednesday, May 27, 2026 at 04:30 PM (IST) to discuss the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026.
The details and schedule with respect to the conference call are enclosed herewith.
The presentation along with the audio recording of the call and the transcript will be hosted on the Company’s website at https://www.marksanspharma.com/earnings-call-transcripts.html
We request you to take the aforesaid on your records.
Thanking you.
Yours faithfully, For Marksans Pharma Limited
Digitally signed by H H PANIGRAHI PANIGRAHI Date: 2026.05.19 12:26:25 +05'30'
Harshavardhan Panigrahi Company Secretary
Encl: As below
Marksans Pharma Ltd.
==> picture [5 x 74] intentionally omitted <==
11[th] Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000
E-mail: [email protected] www.marksanspharma.com
==> picture [126 x 83] intentionally omitted <==
Marksans Pharma Ltd
Q4FY26 Earnings Call CIN: L24110MH1992PLC066364 Wednesday, 27 May 2026 at 16:30 hrs (IST)
DAM Capital Advisors Ltd invites you to Marksans Pharma Ltd’s post results conference call
Marksans Pharma Ltd’s Management Speakers
Mr. Mark Saldanha – Founder, Chairman and Managing Director Mr. Jitendra Sharma – Chief Financial Officer
Call Leaders
Nitin Agarwal – Analyst, DAM Capital Advisors Ltd
Dial-in Details
Universal access : +91 22 6280 1384, +91 22 7115 8285 (accessible from all networks and countries)
Diamond passcode link : click here
International dial-in
| Hong Kong | Singapore | UK | USA | |
|---|---|---|---|---|
| 19:00 (HKT) | 19:00 (SGT) | 12:00 (BST) | 07:00 (EDT) | |
| Toll free | 800964448 | 8001012045 | 08081011573 | 18667462133 |
*Please dial-in at least 5-10 minutes prior to the schedule to get connected to the call in time
For further information please contact
Nitin Agarwal / Payal Shah
DAM Capital Advisors Limited
: +91 22 4202 2568 / 2638